14 result(s) for 'Multiplex'
1 - 10 of 14 results for 'Multiplex'
Sort by
Show
Current technology allows tumors to be painted with multiple colors, termed multiplex staining. Multiplex staining today used in research, may also assist with cancer diagnoses clinically via: preservation of tissue, improved diagnostic accuracy, and enhanced diagnostic insight.
The content of this webinar will encompass detailed technical descriptions of novel and state of the art methods to decalcify tissue samples that will be embedded in paraffin or for frozen sectioning for molecular and nucleic acid analysis for basic research...
In recent years, digital pathology has gone from an intriguing idea to an integral part of how academic and commercial labs operate. Join Leica Biosystems and Procia Digital Pathology as they discuss why institutions are going digital today and how they...
Michael Surace is a scientist at AstraZeneca, where he is responsible for the design, optimization, and validation of multiplex IF panels, as well as imaging and image analysis approaches specifically for the discovery of complex predicitive and prognostic biomarkers for immune oncology.
Blagovesta has worked on projects covering a variety of topics in the life sciences research space including spatial biology, multiplexing, and digital pathology. With over a decade of industry experience, Blagovesta is passionate about to find the right solution for their applications.
Carlee Hemphill is a Lead Scientist I at the Covance CDx laboratory in RTP, NC with a background in histology, anatomical pathology and bioinformatics. Her current role is the development of IHC or multiplex immuno florescence assays, or computational pathology algorithms, for clients interested in a complementary or companion diagnostic testing assay for their immuo-oncology pharmaceutical drug development pipeline.
Following a PhD and postdoc in the field of developmental neurobiology, I joined the experimental histopathology team at the Crick in 2017. Within the science technology platform, I primarily lead on the development and application of advanced staining techniques including immunohistochemistry, immunofluorescence, multiplexed staining, and RNAscope.
Chifei is a senior histotechnologist with GSK R&D. He has broad knowledge and technical skills in routine histology, immunohistochemistry, multiplex immunofluorescence, digital pathology and quantitative image analysis. His work scopes from target validation, animal model characterization to clinical biomarker assay development and validation. He has a master’s degree in neurobiology from Fudan University and a bachelor’s degree in biology from Shandong University in China.
Dean joined Leica Biosystems in 2016 and is a senior scientist in the R&D team in Melbourne, working on advanced staining projects. He graduated from Monash University where he pursued a PhD, with the department of Immunology and Pathology. During this time, he investigated the role of T cell lineages in mediating inflammatory retinal disorders. He assessed cellular interactions using fluorescent multiplex IHC with confocal microscopy imaging of retinal wholemounts.
Tom is the Manager of Product Technology & Strategy at Leica Biosystems. He is currently leading Spatial Profiling new product development focusing on making clinical impacts. He came to LBS three years ago as a Principal Scientist supporting multiplex assay expansion strategies. Tom has been in the IVD industry for 15+ years; he holds a B.S. in Chemistry from Haverford College, a Ph.D. in Chemistry from Duke University and completed postdoctoral studies in Chemical Engineering at the Massachusetts Institute of Technology.